Clinical trial
A Multi-Center, Observational Registry of Subjects With Secondary…
NCT00189501 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00189501 |
|---|---|
| Title | A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD) |
| Official title | A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD) |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Nephrology |
| Intervention type | Drug |
| Interventions | Sensipar® |
| Enrollment | 1,000 |
| Start date | Dec 1, 2004 |
| First posted | Sep 19, 2005 |
| Last update posted | Dec 28, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: